AtaiBeckley (ATAI) EBT (2020 - 2026)
AtaiBeckley's (ATAI) quarterly EBT came in at -$29.8 million in Q1 2026, down 13.2% year-on-year from -$34.3 million in Q1 2025, and down 13.2% quarter-over-quarter from -$26.3 million in Q1 2025.
AtaiBeckley (ATAI) EBT (2020 - 2026) Analysis & Trends
AtaiBeckley (ATAI) has 6 years of EBT data on file, last reported at -$61.0 million in Q3 2025.
- For the quarter ending Q3 2025, EBT fell 130.39% year-over-year to -$61.0 million; the trailing twelve-month figure through Sep 2025 stood at -$154.1 million (down 20.83% YoY), and the FY2024 full-year result was -$148.4 million, down 277.76% from the prior year.
- EBT slipped to -$29.8 million in Q1 2026 per ATAI's latest filing, from -$26.3 million in the prior quarter.
- Across five years, EBT topped out at -$26.3 million in Q1 2025 and bottomed at -$29.8 million in Q1 2026.
- A 5-year average of -$30.2 million and a median of -$31.7 million in 2023 frame the typical range for EBT.
- Across the five-year window, EBT tumbled 841.8% in 2021 and jumped 232.33% in 2023, its largest moves.
- Tracing ATAI's EBT over 5 years: stood at -$48.6 million in 2021, then grew by 19.06% to -$39.3 million in 2022, then soared by 53.41% to -$18.3 million in 2023, then plunged by 113.89% to -$39.2 million in 2024, then slumped by 55.59% to -$61.0 million in 2025.
- Business Quant data shows ATAI's EBT at -$61.0 million in Q3 2025, -$27.7 million in Q2 2025, and -$26.3 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -36.97 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 259.22 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.49 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 831.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 541.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -453.82 Mn |
| 10 | AtaiBeckley | 2.56 Bn | 2.56 Bn | - | -60.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -29.78 Mn |
| Sep 30, 2025 | -60.97 Mn |
| Jun 30, 2025 | -27.65 Mn |
| Mar 31, 2025 | -26.31 Mn |
| Mar 31, 2025 | -26.31 Mn |
| Dec 31, 2024 | -39.18 Mn |
| Sep 30, 2024 | -26.46 Mn |
| Jun 30, 2024 | -57.08 Mn |
| Mar 31, 2024 | -25.68 Mn |
| Dec 31, 2023 | -18.32 Mn |
| Sep 30, 2023 | 43.85 Mn |
| Jun 30, 2023 | -31.66 Mn |
| Mar 31, 2023 | -33.16 Mn |
| Dec 31, 2022 | -39.32 Mn |
| Sep 30, 2022 | -33.13 Mn |
| Jun 30, 2022 | -30.81 Mn |
| Mar 31, 2022 | -31.92 Mn |
| Dec 31, 2021 | -48.58 Mn |
| Sep 30, 2021 | -26.47 Mn |
| Jun 30, 2021 | -67.30 Mn |